Maxim Mallerman
Max graduated with an MChem from The University of Oxford in 2021, after completing his Part II project in the Conway Group. Max’s research focused on the development of hypoxia-activated pro-drugs. Max rejoined the group as part of the redOx⇌KCL team in late 2021, focusing on research into probes for the cellular redox environment. He has since gone on to work in the field of patent law